Kimelman & Baird’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
Kimelman & Baird's FMS Position: Q3 2026 in Review
Kimelman & Baird sold out of Fresenius Medical Care (FMS) in Q3 2026, closing a stake of 9,734 shares — an estimated $220K sold.
Kimelman & Baird first reported a position in FMS in Q2 2015 and held it in 26 quarters. The position peaked at $856K in Q4 2017. 229 funds tracked by Wall St. Rank hold FMS as of Q3 2026.
- Kimelman & Baird reported no remaining Fresenius Medical Care position as of Q3 2026 after selling out during the quarter.
- Kimelman & Baird sold 9,734 Fresenius Medical Care shares in Q3 2026, an estimated $220K.
- Kimelman & Baird first reported a position in Fresenius Medical Care in Q2 2015 and held it in 26 quarters.
- Kimelman & Baird's Fresenius Medical Care position peaked at $856K in Q4 2017.
- 229 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.
Based on Kimelman & Baird's 13F filing for Q3 2026, filed 3 Nov 2026.